Literature DB >> 10952736

Early inflammatory polyarthritis: results from the norfolk arthritis register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis.

D Symmons1, B Harrison.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10952736     DOI： 10.1093/rheumatology/39.8.835

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  13 in total

1.  Perinatal characteristics and risk of rheumatoid arthritis.

Authors:  Lennart T H Jacobsson; Magnus E Jacobsson; Johan Askling; William C Knowler
Journal:  BMJ       Date:  2003-05-17

Review 2.  [Pregnancy in patients with rheumatoid arthritis and inflammatory spondylarthropathies].

Authors:  E Gromnica-Ihle; M Ostensen
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

3.  Prevalence of rheumatoid arthritis in Antalya, Turkey.

Authors:  C Kaçar; E Gilgil; T Tuncer; B Bütün; S Urhan; V Arikan; U Dündar; M C Oksüz; G Sünbüloğlu; C Yildirim; I Tekeoğlu; G Yücel
Journal:  Clin Rheumatol       Date:  2004-11-13       Impact factor: 2.980

4.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

5.  Personal and family medical history correlates of rheumatoid arthritis.

Authors:  Anneclaire J de Roos; Glinda S Cooper; Michael C Alavanja; Dale P Sandler
Journal:  Ann Epidemiol       Date:  2008-03-17       Impact factor: 3.797

6.  Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Authors:  P Stolt; H Källberg; I Lundberg; B Sjögren; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2004-08-19       Impact factor: 19.103

Review 7.  Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.

Authors:  P Stolt; C Bengtsson; B Nordmark; S Lindblad; I Lundberg; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

8.  Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.

Authors:  Rim Sghiri; Elyes Bouagina; Hela Zaglaoui; Hajer Mestiri; Latifa Harzallah; Imed Harrabi; Mehdi Ghannouchi; Faycel Mokhtar; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2007-04-20       Impact factor: 2.631

Review 9.  The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.

Authors:  Annie Yarwood; Tom W J Huizinga; Jane Worthington
Journal:  Rheumatology (Oxford)       Date:  2014-09-18       Impact factor: 7.580

10.  Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.

Authors:  Louise K Mercer; Rebecca Davies; James B Galloway; Audrey Low; Mark Lunt; William G Dixon; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Rheumatology (Oxford)       Date:  2013-01       Impact factor: 7.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.